FDA Inspection
Qualgen, LLCQualgen, LLC – FDA Inspection, Sep 4, 2025
Record Details
This FDA Inspection record concerns Qualgen, LLC, with an inspection on September 4, 2025, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 3723c406-dcfc-4677-9d7f-fce96cf00e62
Inspection Facts
- Inspection number
- 1281118
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.130(a)Prevention of cross contamination, mix-ups
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Qualgen, LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 13, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qualgen, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.